Partnership for Research & Dissemination of Evidence-Based Medicine in Autism

描述（由申请人提供）：我们建议利用创新方法来开发现有循证医学（EBIV！）内容的定制。我们的目标是提供针对自闭症和自闭症谱系障碍（ASD）的产品，并通过社交媒体和其他电子技术渠道评估和传播我们的产品，以面向尚未明确针对或触及的关键利益相关者人群。我们目前正在为AHRQ的iADAPT计划（R18 HS 019271：PI，Mark Harris）资助的项目生成定制的ASD比较有效性研究信息。对于这种合作关系，我们的跨学科团队由南加州大学电影艺术学院的教师领导，建议扩展这项工作，并与主要合作伙伴开发一个高效，统一和可持续的高通量传播基础设施，以提高健康和教育系统，临床实践，护理人员和家庭层面的定制EBM产品的渗透和使用。我们采用创新的方法来开发戏剧性和情感吸引力的视频，网络和互动媒体产品。我们与兰德公司的AHRQ资助的南加州循证实践中心的合作伙伴关系将确保我们的产品准确反映现有ASD EBM产品的内容，并将增强其在决策中的使用、价值和影响。我们将通过基于技术的社交媒体渠道（包括互动网页、Facebook页面）采用高通量传播的新方法。Twitter feed和品牌YouTube频道-使我们的目标利益相关者受众能够快速、轻松地下载超过500万的内容：（1）全国互动自闭症网络中的15 000名自闭症儿童家长;（2）洛杉矶联合学区的3 716名主要是非洲裔美国人和西班牙裔教师;（3）260万农村，低收入，医疗服务不足的成员和1,351提供者在盖辛格卫生系统;和（4）320万种族多样化的成员和8,400提供者在加州最大的非营利性健康计划。北方加州的凯撒医疗机构。我们的基础设施将促进ASD循证医学证据融入医疗保健和教育系统的实践和决策。

DESCRIPTION (provided by the applicant): We propose to utilize innovative methods to develop customizations of content of existing evidence-based medicine (EBIV!) products for autism and autism spectrum disorders (ASD), and to evaluate and disseminate our products through social media and other electronic, technology-based channels to critical stakeholder populations not already specifically targeted or reached. We currently are generating customized ASD comparative effectiveness research information for a project funded by AHRQ's iADAPT program (R18 HS019271: PI, Mark Harris). For this partnership, our trans-disciplinary team led by faculty at the University of Southern California's School of Cinematic Arts proposes to extend this work and develop a highly effective, unified and sustainable high-throughput dissemination infrastructure with key partners to improve the penetration and use of customized EBM products at health and educational systems, clinical practice, caregiver and family levels. We apply innovative approaches to develop dramatic and emotionally engaging videos, webisodes and interactive media products. Our partnership with the AHRQ-funded Southern California Evidence-Based Practice Center at the RAND Corporation will ensure that our products accurately reflects the content of existing ASD EBM products and will enhance their use, value and impact in decision-making. We will employ novel methods of high-throughput dissemination through technology-based and social media channels - including an interactive webpage, Facebook page. Twitter feed and a branded YouTube channel - to enable rapid and easy downloading by our targeted stakeholder audiences of over 5 million: (1) 15,000 parents of ASD children in the nationwide Interactive Autism Network; (2) 3,716 predominately African American and Hispanic teachers in the Los Angeles Unified School District; (3) 2.6 million rural, low income, medically underserved members and 1,351 providers in Geisinger Health System; and (4) 3.2 million ethnically diverse members and 8,400 providers in California's largest nonprofit health plan. Kaiser Permanente Northern California. Our infrastructure will facilitate integration of ASD EBM evidence into practice and decision-making in the health care and education systems.